経皮ドラッグデリバリーシステムの世界市場レポート 2025年

経皮ドラッグデリバリーシステム市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.0％で、550億米ドルに成長します。予測期間の成長は、非侵襲的治療に対する患者の嗜好の高まり、慢性疾患の有病率の上昇、利便性の高いドラッグデリバリーオプションに対する需要の高まり、疼痛管理における用途の拡大、新しいドラッグデリバリーシステムに対する規制当局の支援などの要因によってもたらされます。この期間の主な動向としては、個別化ドラッグデリバリーの革新、吸収率向上のためのナノテクノロジーの利用、スマートパッチの開発、皮膚浸透技術の進歩、生物活性化合物の組み込み、慢性疾患管理用ウェアラブルデバイスの躍進などが挙げられます。

慢性疾患の有病率の増加は、今後の経皮ドラッグデリバリーシステム市場の成長を牽引すると予想されます。糖尿病や心臓病などの慢性疾患は、継続的な管理を必要とし、日常的な活動を制限します。座りっぱなしのライフスタイルは、体重増加、心血管系の健康状態の悪化、代謝のアンバランスなどを引き起こし、慢性疾患の増加の一因となっています。経皮ドラッグデリバリーシステムは、このような疾患において、皮膚から薬剤を持続的に制御放出し、患者の服薬アドヒアランスを向上させ、安定した治療レベルを確保するために使用されます。例えば、2023年6月、Institute for Health Metrics and Evaluationは、世界で5億人以上の人々が糖尿病を患っていると報告し、この数は2050年までに倍増して13億人に達すると予測しています。このように、慢性疾患の蔓延が経皮ドラッグデリバリーシステム市場の拡大を牽引しています。

経皮ドラッグデリバリーシステム市場の主要企業は、薬物吸収と患者のコンプライアンスを向上させるため、マイクロニードル技術などの技術進歩に注力しています。マイクロニードルは、痛みを伴わずに皮膚から薬物を送達する低侵襲デバイスであり、従来の注射に代わる低侵襲な代替手段を提供します。例えば、2024年10月、韓国のDaewoong Pharmaceutical Co.Ltd.は、マイクロニードル・プラットフォームCLOPAMを発表しました。このプラットフォームはドラッグデリバリーの効率を大幅に高め、注射に伴う不快感を最小限に抑え、制御された持続的な薬物放出を実現します。その目的は、経口または注射による治療に代わる、痛みのない一貫した治療法を提供することであり、それにより患者のコンプライアンスと治療効果を向上させることです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界経皮ドラッグデリバリーシステムPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の経皮ドラッグデリバリーシステム市場：成長率分析
• 世界の経皮ドラッグデリバリーシステム市場の実績：規模と成長, 2019-2024
• 世界の経皮ドラッグデリバリーシステム市場の予測：規模と成長, 2024-2029, 2034F
• 世界経皮ドラッグデリバリーシステム総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の経皮ドラッグデリバリーシステム市場処方タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤パッチ
• 貯留層の種類
• マトリックスタイプ
• マイクロリザーバー型
• 世界の経皮ドラッグデリバリーシステム市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• イオントフォレシス
• マイクロオペレーション
• 世界の経皮ドラッグデリバリーシステム市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• 中枢神経系
• 心血管疾患
• 禁煙
• 世界の経皮ドラッグデリバリーシステム市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 在宅ヘルスケア
• 製薬会社
• 調査機関
• 世界の経皮ドラッグデリバリーシステム市場、薬剤パッチの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単層薬剤内接着剤
• 多層薬剤内接着剤
• 世界の経皮ドラッグデリバリーシステム市場貯留層タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゲルリザーバーシステム
• 液体貯蔵システム
• 固体貯留層システム
• 世界の経皮ドラッグデリバリーシステム市場、マトリックスタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリマーマトリックスシステム
• 脂質マトリックスシステム
• ハイドロゲルマトリックスシステム
• 世界の経皮ドラッグデリバリーシステム市場、マイクロリザーバータイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロニードルアレイ
• マイクロエマルジョンリザーバー
• ナノ粒子注入リザーバー

第7章 地域別・国別分析

• 世界の経皮ドラッグデリバリーシステム市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の経皮ドラッグデリバリーシステム市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 経皮ドラッグデリバリーシステム市場：競合情勢
• 経皮ドラッグデリバリーシステム市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GSK plc
• 3M Company
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim GmbH
• Mylan NV
• UCB S.A.
• Skyepharma
• Noven Pharmaceuticals Inc.
• Hisamitsu Pharmaceutical Co. Inc.
• Watson Pharmaceuticals Inc.
• Endo International plc
• Transdermal Technologies Inc.
• Grunenthal GmbH
• 4P Therapeutics LLC
• Actavis Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 経皮ドラッグデリバリーシステム市場2029：新たな機会を提供する国
• 経皮ドラッグデリバリーシステム市場2029：新たな機会を提供するセグメント
• 経皮ドラッグデリバリーシステム市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Transdermal drug delivery systems are methods used to administer medication through the skin, allowing for a controlled, continuous release of the drug into the bloodstream over a period of time. These systems are typically in the form of a patch or similar device applied to the skin, which gradually releases the medication, offering benefits such as avoiding the digestive system and ensuring stable drug levels in the body.

The main types of formulations for transdermal drug delivery systems include drug-in-patch, reservoir, matrix, and microreservoir types. The drug-in-patch formulation is especially common in the consumer health market due to its convenience, making it ideal for treatments such as nicotine replacement and hormone therapy. Key technologies used in transdermal drug delivery include iontophoresis and microporation. These systems are applied in various fields, including pain management, central nervous system disorders, cardiovascular diseases, and smoking cessation, and are used in settings such as hospitals, home healthcare, pharmaceutical companies, and research institutions.

The transdermal drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides transdermal drug delivery systems market statistics, including the transdermal drug delivery systems industry global market size, regional shares, competitors with the transdermal drug delivery systems market share, detailed transdermal drug delivery systems market segments, market trends, and opportunities, and any further data you may need to thrive in the transdermal drug delivery systems industry. This transdermal drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transdermal drug delivery systems market size has grown strongly in recent years. It will grow from $37.30 billion in 2024 to $40.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period can be attributed to factors such as an increased demand for non-invasive drug delivery, better patient adherence to treatments, enhanced bioavailability, a rise in chronic disease prevalence, and a growing preference for self-administration.

The transdermal drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $55.00 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The projected growth in the forecast period is driven by factors including a greater patient preference for non-invasive treatments, the rising prevalence of chronic diseases, an increasing demand for convenient drug delivery options, expanded uses in pain management, and regulatory support for new drug delivery systems. Key trends during this period include innovations in personalized drug delivery, the use of nanotechnology for improved absorption, the development of smart patches, advancements in skin penetration techniques, the incorporation of bioactive compounds, and breakthroughs in wearable devices for managing chronic conditions.

The increasing prevalence of chronic diseases is expected to drive the growth of the transdermal drug delivery systems market in the future. Chronic diseases, such as diabetes and heart disease, require ongoing management and limit daily activities. Factors such as sedentary lifestyles, which lead to weight gain, poor cardiovascular health, and metabolic imbalances, contribute to the rise in chronic conditions. Transdermal drug delivery systems are used in these diseases to provide a continuous, controlled release of medication through the skin, improving patient adherence and ensuring stable therapeutic levels. For example, in June 2023, the Institute for Health Metrics and Evaluation reported that over half a billion people worldwide were living with diabetes, with this number expected to double, reaching 1.3 billion by 2050. Thus, the growing prevalence of chronic diseases is driving the market expansion for transdermal drug delivery systems.

Key players in the transdermal drug delivery systems market are concentrating on technological advancements such as microneedle technology to improve drug absorption and patient compliance. Microneedles are minimally invasive devices that deliver drugs through the skin painlessly, offering a less invasive alternative to traditional injections. For example, in October 2024, Daewoong Pharmaceutical Co. Ltd., a South Korea-based company, launched its microneedle platform CLOPAM. This platform significantly enhances drug delivery efficiency, minimizes the discomfort associated with injections, and provides controlled, sustained medication release. The goal is to offer a painless and consistent alternative to oral or injectable treatments, thereby improving patient compliance and treatment effectiveness.

In August 2022, LTS Lohmann Therapie-Systeme AG, a pharmaceutical company based in Germany, acquired Tapemark Inc. for an undisclosed amount. This acquisition strengthens LTS's drug delivery capabilities, expanding its expertise in production and bolstering its position in the field of transdermal and advanced drug delivery solutions. Tapemark Inc., based in the US, specializes in the manufacturing of transdermal drug delivery systems.

Major players in the transdermal drug delivery systems market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, 3M Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan NV, UCB S.A., Skyepharma, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies, Inc., Grunenthal GmbH, 4P Therapeutics LLC, and Actavis Inc.

North America was the largest region in the transdermal drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transdermal drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the transdermal drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transdermal drug delivery systems market consists of sales of gels, creams, and microneedles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values generated by organizations in the defined geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transdermal Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transdermal drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transdermal drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transdermal drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Formulation Type: Drug-In-Patch; Reservoir Type; Matrix Type; Microreservoir Type
• 2) By Technology: Iontophoresis; Microporation
• 3) By Application: Pain Management; Central Nervous System; Cardiovascular Diseases; Smoking Cessation
• 4) By End User: Hospitals; Home Healthcare; Pharmaceutical Companies; Research Institutes
• Subsegments:
• 1) By Drug-In-Patch: Single-layer Drug-in-Adhesive; Multi-layer Drug-in-Adhesive
• 2) By Reservoir Type: Gel Reservoir Systems; Liquid Reservoir Systems; Solid Reservoir Systems
• 3) By Matrix Type: Polymer Matrix Systems; Lipid Matrix Systems; Hydrogel Matrix Systems
• 4) By Microreservoir Type: Microneedle Arrays; Microemulsion Reservoirs; Nanoparticle-Infused Reservoirs
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transdermal Drug Delivery Systems Market Characteristics

3. Transdermal Drug Delivery Systems Market Trends And Strategies

4. Transdermal Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Transdermal Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

• 5.1. Global Transdermal Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Transdermal Drug Delivery Systems Market Growth Rate Analysis
• 5.4. Global Transdermal Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Transdermal Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Transdermal Drug Delivery Systems Total Addressable Market (TAM)

6. Transdermal Drug Delivery Systems Market Segmentation

• 6.1. Global Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-In-Patch
• Reservoir Type
• Matrix Type
• Microreservoir Type
• 6.2. Global Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iontophoresis
• Microoperation
• 6.3. Global Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Central Nervous System
• Cardiovascular Diseases
• Smoking Cessation
• 6.4. Global Transdermal Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Home Healthcare
• Pharmaceutical Companies
• Research Institutes
• 6.5. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Drug-In-Patch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-layer Drug-in-Adhesive
• Multi-layer Drug-in-Adhesive
• 6.6. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Reservoir Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gel Reservoir Systems
• Liquid Reservoir Systems
• Solid Reservoir Systems
• 6.7. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Matrix Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymer Matrix Systems
• Lipid Matrix Systems
• Hydrogel Matrix Systems
• 6.8. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Microreservoir Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microneedle Arrays
• Microemulsion Reservoirs
• Nanoparticle-Infused Reservoirs

7. Transdermal Drug Delivery Systems Market Regional And Country Analysis

• 7.1. Global Transdermal Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Transdermal Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transdermal Drug Delivery Systems Market

• 8.1. Asia-Pacific Transdermal Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transdermal Drug Delivery Systems Market

• 9.1. China Transdermal Drug Delivery Systems Market Overview
• 9.2. China Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transdermal Drug Delivery Systems Market

• 10.1. India Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transdermal Drug Delivery Systems Market

• 11.1. Japan Transdermal Drug Delivery Systems Market Overview
• 11.2. Japan Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transdermal Drug Delivery Systems Market

• 12.1. Australia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transdermal Drug Delivery Systems Market

• 13.1. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transdermal Drug Delivery Systems Market

• 14.1. South Korea Transdermal Drug Delivery Systems Market Overview
• 14.2. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transdermal Drug Delivery Systems Market

• 15.1. Western Europe Transdermal Drug Delivery Systems Market Overview
• 15.2. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transdermal Drug Delivery Systems Market

• 16.1. UK Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transdermal Drug Delivery Systems Market

• 17.1. Germany Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transdermal Drug Delivery Systems Market

• 18.1. France Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transdermal Drug Delivery Systems Market

• 19.1. Italy Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transdermal Drug Delivery Systems Market

• 20.1. Spain Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transdermal Drug Delivery Systems Market

• 21.1. Eastern Europe Transdermal Drug Delivery Systems Market Overview
• 21.2. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transdermal Drug Delivery Systems Market

• 22.1. Russia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transdermal Drug Delivery Systems Market

• 23.1. North America Transdermal Drug Delivery Systems Market Overview
• 23.2. North America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transdermal Drug Delivery Systems Market

• 24.1. USA Transdermal Drug Delivery Systems Market Overview
• 24.2. USA Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transdermal Drug Delivery Systems Market

• 25.1. Canada Transdermal Drug Delivery Systems Market Overview
• 25.2. Canada Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transdermal Drug Delivery Systems Market

• 26.1. South America Transdermal Drug Delivery Systems Market Overview
• 26.2. South America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transdermal Drug Delivery Systems Market

• 27.1. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transdermal Drug Delivery Systems Market

• 28.1. Middle East Transdermal Drug Delivery Systems Market Overview
• 28.2. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transdermal Drug Delivery Systems Market

• 29.1. Africa Transdermal Drug Delivery Systems Market Overview
• 29.2. Africa Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transdermal Drug Delivery Systems Market Competitive Landscape And Company Profiles

• 30.1. Transdermal Drug Delivery Systems Market Competitive Landscape
• 30.2. Transdermal Drug Delivery Systems Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Transdermal Drug Delivery Systems Market Other Major And Innovative Companies

• 31.1. GSK plc
• 31.2. 3M Company
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Boehringer Ingelheim GmbH
• 31.5. Mylan NV
• 31.6. UCB S.A.
• 31.7. Skyepharma
• 31.8. Noven Pharmaceuticals Inc.
• 31.9. Hisamitsu Pharmaceutical Co. Inc.
• 31.10. Watson Pharmaceuticals Inc.
• 31.11. Endo International plc
• 31.12. Transdermal Technologies Inc.
• 31.13. Grunenthal GmbH
• 31.14. 4P Therapeutics LLC
• 31.15. Actavis Inc.

32. Global Transdermal Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transdermal Drug Delivery Systems Market

34. Recent Developments In The Transdermal Drug Delivery Systems Market

35. Transdermal Drug Delivery Systems Market High Potential Countries, Segments and Strategies

• 35.1 Transdermal Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Transdermal Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Transdermal Drug Delivery Systems Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer